Outcomes & ROI

Clinical outcomes lead.Economic outcomes follow.

Dario is designed to move measurable clinical indicators in-year and validate downstream utilization and cost impact in the data available to each client.

A team of doctors and nurses in scrubs and white coats talking in a hospital corridor

Selected current outcomes

$5,077

annual medical-cost savings per member vs. matched non-users1

23.5%

lower inpatient hospitalization rate in matched claims analysis1,2

9.3%

lower all-cause healthcare utilization in current claims-based evidence3

100+

published studies across the evidence base

Three ways to measure economic impact

Pre/post
claims analysis

Compare medical spend before and after Dario enrollment using paired claims data.

Difference-in-differences

Translate observed improvements in A1c, blood pressure and weight into estimated medical savings using validated cost factors.

Clinical proxy model

Translate observed improvements in A1c, blood pressure and weight into estimated medical savings using validated cost factors.

No double counting

When modeling multi-condition value, overlapping cohorts should be handled explicitly and members counted once per program according to the defined methodology.

Measure over time

Clinical and economic analysis can be evaluated across appropriate 12-, 18- and 24-month windows to understand both initial impact and sustainability.

Talk with Dario about ROI.

Explore the evidence

(1) Sanofi, JMIR 2025.  (2) Dario Clinical Data Overview, July 2026, pp. 21, 22, 26.  (3) Wilson L, et al. J Med Internet Res. 2025;27:e67320. doi:10.2196/67320; Dario Clinical Data Overview, July 2026, pp. 22, 26.